188 related articles for article (PubMed ID: 10934575)
1. Routine hospital alcohol detoxification practice compared to symptom triggered management with an Objective Withdrawal Scale (CIWA-Ar).
Reoux JP; Miller K
Am J Addict; 2000; 9(2):135-44. PubMed ID: 10934575
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the alcohol withdrawal syndrome--validity and reliability of the translated and modified Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-A).
Stuppaeck CH; Barnas C; Falk M; Guenther V; Hummer M; Oberbauer H; Pycha R; Whitworth AB; Fleischhacker WW
Addiction; 1994 Oct; 89(10):1287-92. PubMed ID: 7804089
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the appropriate use of a CIWA-Ar alcohol withdrawal protocol in the general hospital setting.
Eloma AS; Tucciarone JM; Hayes EM; Bronson BD
Am J Drug Alcohol Abuse; 2018; 44(4):418-425. PubMed ID: 28981333
[TBL] [Abstract][Full Text] [Related]
4. Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial.
Melby K; Gråwe RW; Aamo TO; Salvesen Ø; Spigset O
Drug Alcohol Depend; 2019 Apr; 197():95-101. PubMed ID: 30784955
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Alcohol Withdrawal Syndrome: Phenobarbital vs CIWA-Ar Protocol.
Tidwell WP; Thomas TL; Pouliot JD; Canonico AE; Webber AJ
Am J Crit Care; 2018 Nov; 27(6):454-460. PubMed ID: 30385536
[TBL] [Abstract][Full Text] [Related]
6. A comparison of two versions of the clinical institute withdrawal assessment for alcohol: the CIWA-Ar and CIWA-AD.
Reoux JP; Oreskovich MR
Am J Addict; 2006; 15(1):85-93. PubMed ID: 16449097
[TBL] [Abstract][Full Text] [Related]
7. Replacing the Clinical Institute Withdrawal Assessment-Alcohol revised with the modified Richmond Agitation and Sedation Scale for alcohol withdrawal to support management of alcohol withdrawal symptoms: potential impact on length of stay and complications.
de Lemos J; Sharaf M; Moadebi S; Low-Beer S; Cassidy B; Sutherland JM; Deziel C; Nagendran S
CJEM; 2024 Jun; 26(6):431-435. PubMed ID: 38796808
[TBL] [Abstract][Full Text] [Related]
8. The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.
Woods AD; Giometti R; Weeks SM
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):224-52. PubMed ID: 26447017
[TBL] [Abstract][Full Text] [Related]
9. Assessment of a modified MINDS-based protocol for management of alcohol withdrawal syndrome on an inpatient medical service.
Krcmarik KM; Hulley BJ; Huang J; Juang D; Cadman P; Urbiztondo C; Vo C; Vargas J; Motarjemi R; Moinizandi T; Kwan B
Pharmacotherapy; 2023 Dec; 43(12):1297-1306. PubMed ID: 37475509
[TBL] [Abstract][Full Text] [Related]
10. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
[TBL] [Abstract][Full Text] [Related]
11. Increased severity of alcohol withdrawal in in-patient alcoholics with a co-existing anxiety diagnosis.
Johnston AL; Thevos AK; Randall CL; Anton RF
Br J Addict; 1991 Jun; 86(6):719-25. PubMed ID: 1878622
[TBL] [Abstract][Full Text] [Related]
12. Correlation Between mMINDS and CIWA-Ar Scoring Tools in Patients With Alcohol Withdrawal Syndrome.
Littlefield AJ; Heavner MS; Eng CC; Cooper DA; Heavner JJ; Kurtz JM; Pisani MA
Am J Crit Care; 2018 Jul; 27(4):280-286. PubMed ID: 29961663
[TBL] [Abstract][Full Text] [Related]
13. A Symptom-Triggered Benzodiazepine Protocol Utilizing SAS and CIWA-Ar Scoring for the Treatment of Alcohol Withdrawal Syndrome in the Critically Ill.
Sen S; Grgurich P; Tulolo A; Smith-Freedman A; Lei Y; Gray A; Dargin J
Ann Pharmacother; 2017 Feb; 51(2):101-110. PubMed ID: 27733668
[TBL] [Abstract][Full Text] [Related]
14. Development and implementation of an alcohol withdrawal protocol using a 5-item scale, the Brief Alcohol Withdrawal Scale (BAWS).
Rastegar DA; Applewhite D; Alvanzo AAH; Welsh C; Niessen T; Chen ES
Subst Abus; 2017; 38(4):394-400. PubMed ID: 28699845
[TBL] [Abstract][Full Text] [Related]
15. Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment.
Stock CJ; Carpenter L; Ying J; Greene T
Ann Pharmacother; 2013; 47(7-8):961-9. PubMed ID: 23780805
[TBL] [Abstract][Full Text] [Related]
16. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).
Sullivan JT; Sykora K; Schneiderman J; Naranjo CA; Sellers EM
Br J Addict; 1989 Nov; 84(11):1353-7. PubMed ID: 2597811
[TBL] [Abstract][Full Text] [Related]
17. Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome.
Nuss MA; Elnicki DM; Dunsworth TS; Makela EH
W V Med J; 2004; 100(1):21-5. PubMed ID: 15119493
[TBL] [Abstract][Full Text] [Related]
18. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial.
Saitz R; Mayo-Smith MF; Roberts MS; Redmond HA; Bernard DR; Calkins DR
JAMA; 1994 Aug; 272(7):519-23. PubMed ID: 8046805
[TBL] [Abstract][Full Text] [Related]
19. Symptom-Triggered Detoxification Using the Alcohol-Withdrawal-Scale Reduces Risks and Healthcare Costs.
Soravia LM; Wopfner A; Pfiffner L; Bétrisey S; Moggi F
Alcohol Alcohol; 2018 Jan; 53(1):71-77. PubMed ID: 29281047
[TBL] [Abstract][Full Text] [Related]
20. Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidity.
Weaver MF; Hoffman HJ; Johnson RE; Mauck K
J Addict Dis; 2006; 25(2):17-24. PubMed ID: 16785215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
